Hot word :

Home>Science & Nature>Science

Science

iPS Cell Products for Parkinson’s, Heart Disease OK’d for Commercialization by Japan Health Ministry Panel

iPS chart

Return to article

The Yomiuri Shimbun

17:28 JST, February 20, 2026

A health ministry expert panel has approved the commercialization of two regenerative medicine products derived from induced pluripotent stem cells, apparently the first products of their kind in the world.

Add TheJapanNews to your Google News feed.

New contents

JN ACCESS RANKING

Japan PM Takaichi’s Cabinet Resigns en Masse
Japan Institute to Use Domestic Commercial Optical Lattice Clock to Set Japan Standard Time
Israeli Ambassador to Japan Speaks about Japan’s Role in the Reconstruction of Gaza
Man Infected with Measles Reportedly Dined at Restaurant in Tokyo Station
Man Infected with Measles May Have Come in Contact with Many People in Tokyo, Went to Store, Restaurant Around When Symptoms Emerged